Direxion Nanotechnology ETF is a ETF series of Direxion Shares ETF Trust (series S000074011). Net assets $1.3M as of 2023-01-31. Index fund.
Showing 15 of 31 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| DREYFUS GOVERNMENT CASH MANAGEMENT | — | $170K | 1288.15% |
| Bruker Corporation | — | $166K | 1261.13% |
| Beam Therapeutics Incorporation | — | $145K | 1103.14% |
| Bionano Genomics Inc. | — | $80K | 603.74% |
| Arcturus Therapeutics Holdings Inc | — | $77K | 585.51% |
| Liquidia Corporation | — | $64K | 484.22% |
| Roivant Sciences Ltd | — | $55K | 420.82% |
| Nano Dimnsion Ltd | — | $55K | 419.01% |
| Alkermes PLC | — | $43K | 326.09% |
| Lam Research Corporation | — | $39K | 292.10% |
| Lumentum Holdings Incorporation | — | $38K | 285.77% |
| Thermo Fisher Scientific Inc | — | $38K | 285.53% |
| Jazz Pharmaceuticals PLC | — | $37K | 284.02% |
| KLA Corporation | — | $37K | 279.85% |
| Cabot Corporation | — | $37K | 278.28% |
| Report date | Net assets |
|---|---|
| 2023-01-31 | $1.3M |
| 2022-10-31 | $1.6M |
| 2022-07-31 | $1.8M |
| 2022-04-30 | $1.5M |
| 2022-01-31 | $2.0M |